Temsirolimus
Back to searchMolecule Structure
Scientific Name
Temsirolimus
Description of the Drug
Temsirolimus is a antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06287
http://www.drugbank.ca/drugs/DB06287
Brand Name(s)
Torisel
Company Owner(s)
Accord Healthcare Inc, Pf Prism Cv, Gland Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| FK506-binding protein 1A | SINGLE PROTEIN | INHIBITOR | CHEMBL1902 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16848392 | SCHEMBL18792 |
| Human Metabolome Database | HMDB0015632 | |
| DrugBank | DB06287 | |
| PubChem: Thomson Pharma | 14816760 | 14914596 |
| PubChem | 6918289 | |
| PDBe | A4I | |
| BindingDB | 50343413 | |
| EPA CompTox Dashboard | DTXSID2040945 | |
| DrugCentral | 4161 | |
| ChemicalBook | CB3506811 | |
| Guide to Pharmacology | 5892 | |
| rxnorm | TEMSIROLIMUS | TORISEL |
| PubChem: Drugs of the Future | 12014940 | |
| KEGG Ligand | C15182 | |
| ChEBI | 79699 |
